Episodes

  • Stimulant Use Disorder: What Can We Actually Offer?
    5 Nov 2026

    Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

    A patient wants help reducing cocaine or methamphetamine use. Fewer use days, shorter binges, and better daily functioning can be meaningful goals, even when stopping completely feels out of reach. What can we reasonably offer?

    This episode explores bupropion with or without naltrexone, mirtazapine, and topiramate: when each might fit, how co-occurring symptoms and substance use affect the choice, and what to watch for at follow-up. We also discuss contingency management, opioid precautions before naltrexone, and setting realistic expectations for off-label medication trials.

    Visit the episode page for the key clinical takeaways and the downloadable Medications for Stimulant Use Disorder clinical reference, a two-page guide to medication selection, practical dosing, opioid precautions, and follow-up. Keep it nearby when choosing a trial or reviewing whether treatment is helping. The download is available with a free Collaborative Psychiatry account.

    For a related approach to reducing harm while keeping patients engaged, explore Benzodiazepines in the Grey Zone. This case series and clinical toolkit works through complex decisions about ongoing prescribing, co-occurring substance use, and difficult tapers.

    You can also browse more Collaborative Psychiatry QuickTakes.

    Show more Show less
    21 min
  • Antidepressant Augmentation: When One Medication Helps but Not Enough
    19 Oct 2026

    Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

    An antidepressant has made a real difference, but the patient is still struggling. When there is a benefit worth preserving, the next step may be to add treatment for what symptoms remains rather than start over with a different medication. The useful question is: what change are we hoping the add-on will make?

    This episode offers a practical approach to antidepressant augmentation: when it makes sense, how to choose an add-on for a specific goal, and how to tell whether it has earned its place. We discuss bupropion for low energy or SSRI-related sexual side effects, mirtazapine for poor sleep or appetite, and aripiprazole when depression remains disabling. We also address combining antidepressants, mirtazapine dosing, and what to watch for at follow-up.

    Visit the episode page for the key clinical takeaways and the downloadable Antidepressant Augmentation clinical reference—a one-page comparison of bupropion XL, mirtazapine, aripiprazole, brexpiprazole, and quetiapine XR, with practical doses, key cautions, and follow-up checks. The download is available with a free Collaborative Psychiatry account.

    For the broader approach to diagnosis, medication selection, titration, switching, and augmentation, explore the Managing Depression Clinical Framework. It also discusses other augmentation options, including lithium, T3, and modafinil.

    You can also browse more Collaborative Psychiatry QuickTakes.

    Show more Show less
    17 min
  • The Antidepressant Is Helping - But Not Enough
    27 Sep 2026

    Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

    A patient can still say, "I'm depressed," even when an antidepressant has changed something meaningful. Low periods may be shorter, mornings may take less effort, or getting to work may be more reliable. Those changes can be easy to miss if the only question is whether the depression has resolved.

    This episode looks at how to recognize a partial response, check whether the medication has had an adequate trial, and use the response pattern to decide whether to give it more time, optimize the dose, switch antidepressants, or consider augmentation. Side effects, safety, and the patient's priorities may change the usual next step.

    Visit the episode page for the key clinical takeaways and two downloadable resources: Antidepressant Response: Optimize, Switch, or Augment?, a two-page clinical decision tool, and Antidepressant Response Check-In, a worksheet patients can bring to follow-up to describe what has changed. Both downloads are available with a free Collaborative Psychiatry account.

    For a broader approach to diagnosis, medication selection, follow-up, switching, and augmentation, explore the Managing Depression in Primary Care Clinical Framework.

    You can also browse more Collaborative Psychiatry QuickTakes.

    Show more Show less
    15 min
  • Starting a Benzodiazepine Taper Conversation: The Dose Hasn’t Changed, but the Clinical Picture Has
    16 Sep 2026

    Get more practical learning and clinical tools for mental health and substance-use care in outpatient settings at Collaborative Psychiatry.

    A benzodiazepine prescription can remain unchanged for years while the clinical picture around it changes. In this case excerpt, a patient has taken the same clonazepam dose responsibly for more than a decade, but sleep apnea, fatigue, memory concerns, fall risk, alcohol exposure, and improved treatment of his underlying anxiety have created new reasons to reconsider the regimen.

    This episode looks at how to decide whether those changes justify attempting a taper, how to explain the recommendation without blaming the patient or dismissing the medication’s prior benefit, and why starting the conversation does not require reducing the dose that day or committing to a predetermined endpoint.

    Visit the episode page for the key clinical takeaways and the downloadable Benzodiazepine Prescription Review—a two-page clinical tool for clarifying what the medication is doing, what may have changed, what needs stabilization, and what the next treatment goal should be. The download is available with a free Collaborative Psychiatry account.

    For the complete case—including what happens after the first conversation, how the taper is adjusted, and how the eventual endpoint is decided—explore Benzodiazepines in the Grey Zone: A Case Series + Clinical Toolkit.

    You can also browse more Collaborative Psychiatry QuickTakes.

    Show more Show less
    18 min
  • Billing Mental Health Visits Without Losing Your Mind
    27 May 2026

    Get more high-yield learning on psychiatric management in primary care and outpatient practice at collaborative-psychiatry.org.

    Billing for mental health visits can feel murky because the work is often cognitive, conversational, and risk-based rather than procedure- or lab-driven. This episode walks through how to think about billing mental health-related visits using medical decision making, time-based E/M billing, and a few key add-on codes.

    For access to the high yield take-aways as well as the downloadable clinical references associated with this episode, visit the Episode Page. There, Free Members will find:

    • A practical quick-reference guide for using MDM and time-based billing in mental health-related visits, including risk factors that often support moderate complexity.
    • Case-based billing examples and documentation language for MDM, time-based E/M, psychotherapy add-ons, and prolonged services.

    For deeper training in outpatient mental health decision-making, explore Collaborative Psychiatry’s CME-accredited audio courses on depression, ADHD, and alcohol use disorder at our Audio Courses page.

    Show more Show less
    17 min
  • How I Choose a First-Line Antidepressant (Course Excerpt)
    9 Feb 2026

    Season 1 of Collaborative Psychiatry QuickTakes may be complete, but the learning continues.

    In this episode, I’m sharing a short excerpt from the full Audio Course Managing Depression in Primary Care. This clip walks through a practical framework for choosing a first-line antidepressant and setting expectations so patients stay on treatment long enough to see benefit.

    You’ll hear:

    • How I choose between bupropion, escitalopram, and sertraline
    • How side effect profiles guide initial selection
    • How to frame the “we don’t know which one will work yet” conversation
    • Why anticipatory guidance about placebo response and timing matters

    If you’ve been enjoying the QuickTakes, this excerpt gives you a feel for how the full Audio Courses go deeper with structured, practical, and high-yield learning designed for real-world outpatient care.

    Explore More

    Get more high-yield psychiatric education for primary care and outpatient clinicians at: collaborative-psychiatry.org

    Audio Courses Available Now
    • Managing Depression in Primary Care: A comprehensive framework for diagnosis, screening, medication selection, switching and augmentation strategies, treatment-resistant depression, and the broader treatment landscape including psychotherapy, neuromodulation, and ketamine/esketamine.
    Coming Soon
    • ADHD Pharmacology: A Practical Prescribing Framework
    • Managing Alcohol Use Disorder
    Keep the Learning in Your Back Pocket

    If you’ve been listening to the QuickTakes, don’t forget to download the associated PDF clinic resources and patient handouts available on each episode page. These quick-reference tools are designed to support you in real time — in the exam room, not just in your earbuds.

    Check out all the available resources here.

    Show more Show less
    10 min
  • Naltrexone Demystified: From Craving to Control
    26 Jan 2026

    Get more high-yield learning on psychiatric management in primary care and outpatient practice at collaborative-psychiatry.org.

    Naltrexone is a safe, effective, and often underutilized option for treating alcohol use disorder or even just problematic drinking in primary care. In this episode, we walk through how it works, how to prescribe it, and how to counsel patients on what to expect. You’ll learn practical strategies for dosing, managing side effects, navigating liver function, concurrent opioid use, and the use of approaches like the Sinclair Method when daily use isn’t the patient's goal. Whether you’re already prescribing naltrexone or just getting comfortable with it, this episode offers clear, actionable insights to support your patients and expand your toolkit.

    For access to the Show Notes as well as the downloadable clinical references and patients handouts associated with this episode, visit the Episode Page. There, Free Members will find:

    • A quick-reference sheet for naltrexone use in primary care and outpatient settings
    • A reference sheet with counseling tips and scripts for prescribing naltrexone for AUD
    • A handout comparing naltrexone with other AUD medications
    • A patient handout on naltrexone for AUD

    For a deep dive on managing alcohol use disorder in primary care as well as outpatient mental health settings, check out our Audio Course Managing Alcohol Use Disorder. We have a full course on Managing Alcohol Use Disorder in primary care and outpatient settings coming soon.

    Show more Show less
    15 min
  • Two New Antidepressants You're Probably Not Using But Should Consider
    12 Jan 2026

    Get more high-yield learning on psychiatric management in primary care and outpatient practice at collaborative-psychiatry.org.

    In this episode, we explore two underused antidepressants—vilazodone (Viibryd) and vortioxetine (Trintellix)—that offer important advantages over traditional SSRIs, particularly when it comes to minimizing sexual side effects and weight gain. You'll learn how these medications work, how to dose them effectively, and where they fit into real-world treatment strategies. By the end, you’ll be able to identify how vilazodone and vortioxetine differ from traditional SSRIs, compare their side effect profiles, understand titration schedules, and determine when to consider them as part of your antidepressant selection framework.

    For access to the Show Notes as well as the downloadable clinical references and patients handouts associated with this episode, visit the Episode Page. There, QuickTake Members will find:

    • A visual flowchart guiding clinical use of Vilazodone and Vortioxetine.
    • A quick-reference table comparing clinically relevant aspects of Vilazodone, Vortioxetine and traditional SSRIs.
    • An informational handout for patients considering or being prescribed Vilazodone.
    • An informational handout for patients considering or being prescribed Vortioxetine.

    For a deep dive on managing antidepressants and treating depression in primary care, check out our Audio Course Managing Depression in Primary Care.

    Learning Objectives

    By the end of this episode, you'll be able to:

    1. Identify the key differences between vilazodone, vortioxetine, and traditional SSRIs.
    2. Compare side effect profiles, especially regarding weight gain and sexual dysfunction.
    3. Apply practical dosing and titration strategies for these two medications.
    4. Determine where these medications fit in your antidepressant treatment algorithm.
    Show more Show less
    15 min